Therapy News and Research

RSS

1 in 6 patients with colorectal cancer found to have inherited genetic mutations

A new Mayo Clinic study bolsters evidence that colorectal cancer is often imprinted in family genes and passed on from one generation to the next.

20 Apr 2021

Nearly 20% of U.S. adults experience chronic pain

Chronic pain is among the most common chronic conditions in the United States, but estimates of its prevalence and impact vary widely.

20 Apr 2021

From rotten teeth to advanced cancer, patients feel the effects of treatment delays

With medical visits picking up again among patients vaccinated against Covid-19, health providers are starting to see the consequences of a year of pandemic-delayed preventive and emergency care as they find more advanced cancer and rotting and damaged teeth, among other ailments.

20 Apr 2021

Policies designed to prevent opioid misuse may limit access to pain-relieving drugs

Policies designed to prevent the misuse of opioids may have the unintended side effect of limiting access to the pain-relieving drugs by terminally ill patients nearing the end of their life, new research led by the Oregon State University College of Pharmacy suggests.

20 Apr 2021

Study identifies strengths and specific challenges among young autistic drivers

A collaborative study from the Center for Injury Research and Prevention (CIRP) and the Center for Autism Research (CAR) at Children's Hospital of Philadelphia (CHOP) identified clear strengths and a series of specific challenges autistic adolescents experience while learning to drive.

20 Apr 2021

Immune tolerance in hemophilia can be modulated by B cell activating factor

A group of scientists have just made a key discovery that could prevent and eradicate immune responses that lead to treatment failure in about one-third of people with severe hemophilia A.

20 Apr 2021

Study uncovers role for STING in regulating tumor response to DNA-damaging treatments

In a study by Yale Cancer Center, researchers report on the discovery of a new role for STimulator of INterferon Genes or STING.

19 Apr 2021

Building world’s first prototype to track moving tumors with real-time MRI during proton therapy

Researchers at the Helmholtz-Zentrum Dresden-Rossendorf want to build the world's first prototype that tracks moving tumors with magnetic resonance imaging (MRI) in real time during proton therapy.

19 Apr 2021

Study shows adverse outcomes associated with use of more blood thinners

More blood thinners aren't automatically better, another study confirms. A new publication in JAMA Internal Medicine focuses on the minimal pros and the concerning cons of combining a daily aspirin with a drug from the newer class of anticoagulants that include apixaban, dabigatran, edoxaban and rivaroxaban.

19 Apr 2021

Topical drug regenerates, restores function of erectile nerves damaged by radical prostatectomy

Researchers at Albert Einstein College of Medicine have developed a topical drug that regenerates and restores the function of erectile nerves damaged by radical prostatectomy, the most common treatment for localized prostate cancer.

19 Apr 2021

Once-a-week injectable insulin therapy proves to be safe, effective in people with Type 2 diabetes

Treating people with Type 2 diabetes with a new once-a-week injectable insulin therapy proved to be safe and as effective as daily insulin injections, according to the results of two international clinical trials published online today in Diabetes Care.

19 Apr 2021

Light therapy offers a safe, cost-effective alternative for treatment of neurodegenerative diseases

A lot about the human brain and its intricacies continue to remain a mystery. With the advancement of neurobiology, the pathogenesis of several neurodegenerative diseases (ND) has been uncovered to a certain extent along with molecular targets around which current therapies revolve.

19 Apr 2021

Study sheds new light on the ability of pancreatic cancer cells to metastasize

With an overall survival rate of 9% for those diagnosed, pancreatic cancer remains exceedingly difficult to treat. However, the patient's primary tumor typically isn't what leads to death - it is the cancer's ability to evade detection and metastasize to other organs.

19 Apr 2021

MIPT and Harvard researchers grow and transplant retinal ganglion cells to treat glaucoma

A joint research carried out by MIPT scientists and Harvard researchers have presented retinal cells that can integrate into the retina.

19 Apr 2021

Gene therapy for common forms of congenital blindness shows promise to improve vision

A new gene therapy for one of the most common forms of congenital blindness was safe and improved patients' vision, according to initial data from a clinical trial led by researchers at the Scheie Eye Institute in the Perelman School of Medicine at the University of Pennsylvania.

19 Apr 2021

Mirati to contribute $4 million grant to support SU2C research on KRAS mutant cancers

Stand Up To Cancer and Mirati Therapeutics Inc. - a late-stage targeted oncology company - today announced that Mirati will contribute a $4 million grant to SU2C to develop new approaches to treat patients with KRAS mutant cancers, as a part of the SU2C Catalyst program.

19 Apr 2021

Phico Therapeutics awarded up to $18.2 million USD (c.£13.2 million GBP) CARB-X funding to advance SASPject antibacterial therapy through Phase 1 clinical trials

Phico Therapeutics has been awarded a grant of up to $18.2 million USD to tackle the global rising threat of drug-resistant bacteria.

From Phico Therapeutics 19 Apr 2021

Therapy News and Research

1 in 6 patients with colorectal cancer found to have inherited genetic mutations

Nearly 20% of U.S. adults experience chronic pain

From rotten teeth to advanced cancer, patients feel the effects of treatment delays

Policies designed to prevent opioid misuse may limit access to pain-relieving drugs

Study identifies strengths and specific challenges among young autistic drivers

Immune tolerance in hemophilia can be modulated by B cell activating factor

Study uncovers role for STING in regulating tumor response to DNA-damaging treatments

Building world’s first prototype to track moving tumors with real-time MRI during proton therapy

Study shows adverse outcomes associated with use of more blood thinners

Topical drug regenerates, restores function of erectile nerves damaged by radical prostatectomy

Once-a-week injectable insulin therapy proves to be safe, effective in people with Type 2 diabetes

Light therapy offers a safe, cost-effective alternative for treatment of neurodegenerative diseases

Study sheds new light on the ability of pancreatic cancer cells to metastasize

MIPT and Harvard researchers grow and transplant retinal ganglion cells to treat glaucoma

Gene therapy for common forms of congenital blindness shows promise to improve vision

Mirati to contribute $4 million grant to support SU2C research on KRAS mutant cancers

Phico Therapeutics awarded up to $18.2 million USD (c.£13.2 million GBP) CARB-X funding to advance SASPject antibacterial therapy through Phase 1 clinical trials

Gender-affirming hormone therapy linked to blood pressure changes in transgender people

Antibodies may not inhibit SARS-COV-2 variants from mink

Five-year study aims to improve health of patients with cystic fibrosis across their growing lifespan

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News